Arbutus Biopharma Corp (ABUS)
2.685
-0.04
(-1.65%)
USD |
NASDAQ |
May 01, 16:00
2.685
0.00 (0.00%)
After-Hours: 19:17
Arbutus Biopharma Price: 2.685 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 2.77 | 2.795 | 2.73 | 2.73 | 994273.0 |
Apr 29, 2024 | 2.75 | 2.80 | 2.74 | 2.78 | 626162.0 |
Apr 26, 2024 | 2.73 | 2.78 | 2.70 | 2.73 | 406742.0 |
Apr 25, 2024 | 2.74 | 2.75 | 2.68 | 2.72 | 323341.0 |
Apr 24, 2024 | 2.75 | 2.78 | 2.735 | 2.75 | 348057.0 |
Apr 23, 2024 | 2.64 | 2.75 | 2.64 | 2.75 | 1.089M |
Apr 22, 2024 | 2.73 | 2.765 | 2.635 | 2.64 | 740415.0 |
Apr 19, 2024 | 2.71 | 2.81 | 2.65 | 2.72 | 931457.0 |
Apr 18, 2024 | 2.78 | 2.80 | 2.69 | 2.73 | 1.017M |
Apr 17, 2024 | 2.91 | 2.938 | 2.78 | 2.78 | 710512.0 |
Apr 16, 2024 | 2.94 | 2.94 | 2.88 | 2.92 | 644013.0 |
Apr 15, 2024 | 2.90 | 2.99 | 2.82 | 2.97 | 3.626M |
Apr 12, 2024 | 2.99 | 3.03 | 2.90 | 2.91 | 666195.0 |
Apr 11, 2024 | 2.95 | 3.05 | 2.94 | 3.03 | 860344.0 |
Apr 10, 2024 | 3.01 | 3.02 | 2.90 | 2.98 | 1.114M |
Apr 09, 2024 | 3.06 | 3.11 | 3.00 | 3.005 | 798622.0 |
Apr 08, 2024 | 3.17 | 3.185 | 3.03 | 3.09 | 1.226M |
Apr 05, 2024 | 3.02 | 3.29 | 2.98 | 3.12 | 6.083M |
Apr 04, 2024 | 2.93 | 3.11 | 2.86 | 3.00 | 8.084M |
Apr 03, 2024 | 2.51 | 3.25 | 2.30 | 2.92 | 12.48M |
Apr 02, 2024 | 2.52 | 2.537 | 2.485 | 2.52 | 450651.0 |
Apr 01, 2024 | 2.61 | 2.61 | 2.545 | 2.56 | 486654.0 |
Mar 28, 2024 | 2.59 | 2.61 | 2.55 | 2.58 | 525829.0 |
Mar 27, 2024 | 2.49 | 2.60 | 2.48 | 2.60 | 830398.0 |
Mar 26, 2024 | 2.53 | 2.53 | 2.47 | 2.49 | 375260.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.87
Minimum
Oct 09 2019
6.20
Maximum
Jul 23 2020
2.657
Average
2.64
Median
Jun 02 2022
Price Benchmarks
Moderna Inc | 111.57 |
Pacira BioSciences Inc | 26.94 |
Chimerix Inc | 0.9467 |
Karyopharm Therapeutics Inc | 1.085 |
Corvus Pharmaceuticals Inc | 1.64 |
Price Related Metrics
PS Ratio | 24.56 |
Price to Book Value | 4.563 |
Earnings Yield | -16.39% |
Market Cap | 483.77M |